AII vs ACA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

AII

39.0
AI Score
VS
ACA Wins

ACA

57.5
AI Score

Investment Advisor Scores

AII

39score
Recommendation
SELL

ACA

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AII ACA Winner
Revenue 1.23B 206.10M ACA
Net Income 366.30M 54.06M ACA
Net Margin 29.8% 26.2% ACA
ROE 12.3% 14.6% AII
ROA 6.9% 3.4% ACA
Total Assets 5.30B 1.61B ACA
Cash 432.10M 288.45M ACA
Free Cash Flow -41.60M 125.37M AII

Relative Price Performance (Last 90 Days)

AII 1M: +10.8% · 3M: +60.3% ACA 1M: +1.7% · 3M: +2.7%

Current Technical Phase

AII

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.9% over 20 days), RSI 71

RSI (14): 70.9 · Price: $28.77

ACA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.5% over 20 days), RSI 82

RSI (14): 81.5 · Price: $149.03

Fundamentals Snapshot

Metric AII ACA
Market Cap — —
Forward P/E 8.8 29.1
Trailing P/E 6.3 36.3
Revenue (TTM) — —
Revenue Growth 0.5% 0.0%
Gross Margin 0.5% 0.2%
Operating Margin 0.4% 0.1%
EPS 4.57 4.06
Dividend Yield 0.00% 0.00%

Frequently Asked Questions

Based on our detailed analysis, ACA is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.